NCT03302052 is a clinical trial in Advance Directive, sponsored by Fondation Hôpital Saint-Joseph.

Who is sponsoring NCT03302052?

NCT03302052 is sponsored by Fondation Hôpital Saint-Joseph.

What condition does NCT03302052 study?

NCT03302052 studies Advance Directive.

Is NCT03302052 still recruiting?

NCT03302052 is currently completed. Last updated 4 October 2017.

Last reviewed 2017-10-04 · How we verify

NCT03302052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation About Advance Directives

Completed Last updated 4 October 2017

What this trial tests

trial in Advance Directive in 100 participants. Completed in 31 December 2016.

Timeline

27 May 2016

Primary endpoint
30 September 2016

31 December 2016

Quick facts

Lead sponsor	Fondation Hôpital Saint-Joseph
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	27 May 2016
Primary completion	30 September 2016
Estimated completion	31 December 2016
Sites	1 location across France

Conditions studied

Advance Directive — all drugs for Advance Directive →

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Advance Directive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Advance directives are again in the heart of debate since the Leonetti-Claeys's law . These pieces of legislation allow everyone to decide by advance their wishes of the end of life.However, it does not seem that to legislate on a subject is enough to apply the text of law. High authority of health suggest that medical and paramedical staff have to participate to the elaboration of the questionnaire and the redaction of advance directives. So the aim is that ,before asking patient about their knowledge on these advance directive, to evaluate if the staff knows about the law .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

NCT07512960 — Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization · Phase 3 · not yet recruiting
NCT07512908 — Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Di · NA · not yet recruiting
NCT07512830 — Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography · NA · recruiting
NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
NCT07086612 — Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03302052 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondation Hôpital Saint-Joseph
Last refreshed: 4 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03302052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing